These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 15799394

  • 1. [Lesson from ACR guidelines for management of RA].
    Abe T.
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():431-8. PubMed ID: 15799394
    [No Abstract] [Full Text] [Related]

  • 2. Anticytokine therapy--a new era in the treatment of rheumatoid arthritis?
    O'Dell JR.
    N Engl J Med; 1999 Jan 28; 340(4):310-2. PubMed ID: 9920958
    [No Abstract] [Full Text] [Related]

  • 3. New drugs for rheumatoid arthritis.
    Messori A, Santarlasci B, Vaiani M.
    N Engl J Med; 2004 Aug 26; 351(9):937-8. PubMed ID: 15329436
    [No Abstract] [Full Text] [Related]

  • 4. [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society].
    Salvarani C, Olivieri I, Cantini F, Marchesoni A, Punzi L, Scarpa R, Matucci-Cerinic M.
    Reumatismo; 2004 Aug 26; 56(3):133-4, 136-8. PubMed ID: 15470517
    [No Abstract] [Full Text] [Related]

  • 5. Rheumatoid arthritis.
    Burchini G, Orsi C.
    N Engl J Med; 2004 Sep 23; 351(13):1360-1; author reply 1360-1. PubMed ID: 15385669
    [No Abstract] [Full Text] [Related]

  • 6. Rheumatoid arthritis.
    Emery P, Suarez-Almazor M.
    Clin Evid; 2003 Jun 23; (9):1349-71. PubMed ID: 15366179
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ, van de Putte LB, Breedveld FC.
    Ned Tijdschr Geneeskd; 2001 Sep 29; 145(39):1880-5. PubMed ID: 11605312
    [Abstract] [Full Text] [Related]

  • 8. Etanercept in rheumatoid arthritis.
    Cook DA, Dimick JB, Gallagher DC.
    N Engl J Med; 1999 Jun 24; 340(25):2000; author reply 2001. PubMed ID: 10383273
    [No Abstract] [Full Text] [Related]

  • 9. [Anakinra for therapy of rheumatoid arthritis].
    Tomoo T, Sumida T.
    Nihon Rinsho; 2005 Jan 24; 63 Suppl 1():534-7. PubMed ID: 15799413
    [No Abstract] [Full Text] [Related]

  • 10. Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis.
    Blank N, Max R, Schiller M, Briem S, Lorenz HM.
    Rheumatology (Oxford); 2009 Apr 24; 48(4):440-1. PubMed ID: 19153143
    [No Abstract] [Full Text] [Related]

  • 11. TNFalpha antagonists in rheumatoid arthritis patients seen in everyday practice.
    Falgarone G, Duclos M, Boissier MC.
    Joint Bone Spine; 2007 Dec 24; 74(6):523-6. PubMed ID: 18092377
    [No Abstract] [Full Text] [Related]

  • 12. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E, Wipff J, Avouac J, Kahan A, Allanore Y.
    J Rheumatol; 2009 Sep 24; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract] [Full Text] [Related]

  • 13. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
    Keystone E, Freundlich B, Schiff M, Li J, Hooper M.
    J Rheumatol; 2009 Mar 24; 36(3):522-31. PubMed ID: 19228659
    [Abstract] [Full Text] [Related]

  • 14. [So that the patients.would be able to move for a long time after first diagnosis of rheumatism. Approach as an emergency!].
    Fath R.
    MMW Fortschr Med; 2004 Sep 09; 146(37):4-5. PubMed ID: 15887690
    [No Abstract] [Full Text] [Related]

  • 15. Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials.
    Pincus T, Yazici Y, van Vollenhoven R.
    J Rheumatol; 2006 Dec 09; 33(12):2372-5. PubMed ID: 17143975
    [No Abstract] [Full Text] [Related]

  • 16. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
    Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ.
    N Engl J Med; 1999 Jan 28; 340(4):253-9. PubMed ID: 9920948
    [Abstract] [Full Text] [Related]

  • 17. Current management: Management of rheumatic diseases in the era of biological anti-rheumatic drugs.
    Konttinen YT, Seitsalo S, Lehto M, Santavirta S.
    Acta Orthop; 2005 Oct 28; 76(5):614-9. PubMed ID: 16263606
    [No Abstract] [Full Text] [Related]

  • 18. Maintaining and optimising anti-TNF therapy.
    Somerville M.
    Musculoskeletal Care; 2007 Dec 28; 5 Suppl 1():1-17. PubMed ID: 18050263
    [No Abstract] [Full Text] [Related]

  • 19. Etanercept in rheumatoid arthritis.
    Ferraccioli GF, Di Poi E.
    N Engl J Med; 1999 Jun 24; 340(25):2000-1. PubMed ID: 10383275
    [No Abstract] [Full Text] [Related]

  • 20. Disease-modifying antirheumatic drugs: enhancing efficacy by combination.
    Schnabel A.
    Lancet; 2004 Feb 28; 363(9410):670-1. PubMed ID: 15001319
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.